These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19058138)

  • 1. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.
    Arcuri F; Cintorino M; Florio P; Floccari F; Pergola L; Romagnoli R; Petraglia F; Tosi P; Teresa Del Vecchio M
    Prostate; 2002 Aug; 52(3):167-72. PubMed ID: 12111693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation.
    Tezval H; Jurk S; Atschekzei F; Becker JU; Jahn O; Serth J; Kuczyk MA
    World J Urol; 2009 Dec; 27(6):825-30. PubMed ID: 19437022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2.
    Wang J; Xu Y; Xu Y; Zhu H; Zhang R; Zhang G; Li S
    Cancer Invest; 2008 May; 26(4):359-68. PubMed ID: 18443956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin expression is downregulated in human endometrial carcinoma.
    Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
    J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis.
    Chatzaki E; Lambropoulou M; Constantinidis TC; Papadopoulos N; Taché Y; Minopoulos G; Grigoriadis DE
    J Cell Physiol; 2006 Dec; 209(3):905-11. PubMed ID: 16972272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor expression and angiogenesis in human prostate carcinoma.
    Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
    Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone receptor expression in the human prostate.
    Tieva A ; Stattin P; Wikström P; Bergh A; Damber JE
    Prostate; 2001 Jun; 47(4):276-84. PubMed ID: 11398175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
    Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells.
    Wang J; Jin L; Chen J; Li S
    Cancer Invest; 2010 Feb; 28(2):146-55. PubMed ID: 19968503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia].
    Tezval H; Merseburger AS; Seidler M; Serth J; Kuczyk MA; Oelke M
    Urologe A; 2008 Sep; 47(9):1079-80, 1082-4. PubMed ID: 18670748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
    Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
    J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of neuropeptide urocortin and its receptors in human allergic nasal mucosa.
    Kim TH; Lee SH; Lee HM; Lee SH; Lee SW; Kim WJ; Park SJ; Kim YS; Choe H; Hwang HY; Yoo IO
    Laryngoscope; 2007 Sep; 117(9):1513-8. PubMed ID: 17597629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A; Blount A; Vaughan J; Brar B; Vale W
    Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
    Ho LL; Kench JG; Handelsman DJ; Scheffer GL; Stricker PD; Grygiel JG; Sutherland RL; Henshall SM; Allen JD; Horvath LG
    Prostate; 2008 Sep; 68(13):1421-9. PubMed ID: 18615486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Charalampopoulos I; Spiess J; Gravanis A; Margioris AN
    FEBS Lett; 2005 Aug; 579(20):4259-64. PubMed ID: 16054139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.